CANCER CAPITAL CORP. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dd3828f8-3e19-49a9-a321-b1007cdf1fdd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-14.9k | 2023-01-01 – 2023-12-31 | evidence 0001554795-24-000087 |
| FY 2022 | $-21.0k | 2022-01-01 – 2022-12-31 | evidence 0001554795-23-000097 |
| FY 2021 | $-18.3k | 2021-01-01 – 2021-12-31 | evidence 0001554795-22-000107 |
| FY 2020 | $-13.5k | 2020-01-01 – 2020-12-31 | evidence 0001554795-21-000089 |
| FY 2019 | $-13.6k | 2019-01-01 – 2019-12-31 | evidence 0001554795-20-000101 |
| FY 2018 | $-13.5k | 2018-01-01 – 2018-12-31 | evidence 0001554795-19-000061 |
| FY 2017 | $-13.4k | 2017-01-01 – 2017-12-31 | evidence 0001554795-18-000059 |
| FY 2016 | $-13.9k | 2016-01-01 – 2016-12-31 | evidence 0001554795-17-000097 |
| FY 2015 | $-15.5k | 2015-01-01 – 2015-12-31 | evidence 0001554795-16-000580 |
| FY 2014 | $-17.1k | 2014-01-01 – 2014-12-31 | evidence 0001554795-15-000077 |
| FY 2013 | $-189.1k | 1997-04-11 – 2014-03-31 | evidence 0001554795-14-000354 |
| FY 2012 | $-164.3k | 1997-04-11 – 2013-03-31 | evidence 0001548123-13-000156 |
| FY 2011 | $-135.2k | 1997-04-11 – 2012-03-31 | evidence 0001548123-12-000027 |
| FY 2010 | $-5.7k | 2010-01-01 – 2010-12-31 | evidence 0001010412-12-000111 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).